Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy | Zendy

Nada Dimković | Zendy; Tanja Djordjevic | Zendy; Jovan Popović | Zendy; Siniša Dimković | Zendy; Biserka TirmenštajnJanković | Zendy; Milenko Živanović | Zendy; Svetlana Zikic | Zendy; Jasminka Bobanovic-Haskovic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy

Author(s) -

Nada Dimković,

Tanja Djordjevic,

Jovan Popović,

Siniša Dimković,

Biserka TirmenštajnJanković,

Milenko Živanović,

Svetlana Zikic,

Jasminka Bobanovic-Haskovic

Publication year - 2006

Publication title -

srpski arhiv za celokupno lekarstvo

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.135

H-Index - 17

eISSN - 2406-0895

pISSN - 0370-8179

DOI - 10.2298/sarh0602044d

Subject(s) - medicine , fosinopril , enalapril , hyperkalemia , hemodialysis , blood pressure , dialysis , cardiology , left ventricular hypertrophy , angiotensin converting enzyme , urology

Hypertension is evident in 80%-85% of patients with chronic renal failure and antihypertensive therapy is needed in 25%-30% of patients. Apart from antihypertensive effect, ACEi's decrease the left ventricular hypertrophy and mortality in dialysis patients. Even so, their use is limited due to hyperkalemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research